Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 97

1.

Endoglin selectively modulates transient receptor potential channel expression in left and right heart failure.

Morine KJ, Paruchuri V, Qiao X, Aronovitz M, Huggins GS, DeNofrio D, Kiernan MS, Karas RH, Kapur NK.

Cardiovasc Pathol. 2016 Nov - Dec;25(6):478-482. doi: 10.1016/j.carpath.2016.08.004. Epub 2016 Aug 21.

PMID:
27614169
2.

Biventricular Circulatory Support Using 2 Axial Flow Catheters for Cardiogenic Shock Without the Need for Surgical Vascular Access.

Aghili N, Bader Y, Vest AR, Kiernan MS, Kimmelstiel C, DeNofrio D, Kapur NK.

Circ Cardiovasc Interv. 2016 Jun;9(6). pii: e003636. doi: 10.1161/CIRCINTERVENTIONS.116.003636. No abstract available.

3.

Preoperative Determinants of Quality of Life and Functional Capacity Response to Left Ventricular Assist Device Therapy.

Kiernan MS, Sundareswaran KS, Pham DT, Kapur NK, Pereira NL, Strueber M, Farrar DJ, DeNofrio D, Rogers JG.

J Card Fail. 2016 Oct;22(10):797-805. doi: 10.1016/j.cardfail.2016.01.006. Epub 2016 Jan 14.

PMID:
26777757
4.

Pulmonary Artery Pulsatility Index Is Associated With Right Ventricular Failure After Left Ventricular Assist Device Surgery.

Morine KJ, Kiernan MS, Pham DT, Paruchuri V, Denofrio D, Kapur NK.

J Card Fail. 2016 Feb;22(2):110-6. doi: 10.1016/j.cardfail.2015.10.019. Epub 2015 Nov 10.

PMID:
26564619
5.

Incidence, Management, and Outcome of Suspected Continuous-Flow Left Ventricular Assist Device Thrombosis.

Upshaw JN, Kiernan MS, Morine KJ, Kapur NK, DeNofrio D.

ASAIO J. 2016 Jan-Feb;62(1):33-9. doi: 10.1097/MAT.0000000000000294.

PMID:
26479464
6.

First Successful Use of 2 Axial Flow Catheters for Percutaneous Biventricular Circulatory Support as a Bridge to a Durable Left Ventricular Assist Device.

Kapur NK, Jumean M, Ghuloom A, Aghili N, Vassallo C, Kiernan MS, DeNofrio D, Pham DT.

Circ Heart Fail. 2015 Sep;8(5):1006-8. doi: 10.1161/CIRCHEARTFAILURE.115.002374. No abstract available.

7.

Ventricular square-wave response: case illustrating the role of invasive hemodynamics in the management of continuous-flow left ventricular assist device dysfunction.

Kapur NK, Jumean M, Halin N, Kiernan MS, DeNofrio D, Pham DT.

Circ Heart Fail. 2015 May;8(3):652-4. doi: 10.1161/CIRCHEARTFAILURE.115.002160. No abstract available.

8.

Bridging with half-therapeutic dose enoxaparin in outpatients with left ventricular assist devices and sub-therapeutic international normalized ratios.

Borden M, Kiernan MS, Pham DT, DeNofrio D, Sylvia L.

J Heart Lung Transplant. 2015 Jun;34(6):860-2. doi: 10.1016/j.healun.2015.01.981. Epub 2015 Feb 7. No abstract available.

PMID:
25841651
9.

Hemodynamic effects of standard versus larger-capacity intraaortic balloon counterpulsation pumps.

Kapur NK, Paruchuri V, Majithia A, Esposito M, Shih H, Weintraub A, Kiernan M, Pham DT, Denofrio D, Kimmelstiel C.

J Invasive Cardiol. 2015 Apr;27(4):182-8.

10.

BK Virus Nephropathy in Heart Transplant Recipients.

Joseph A, Pilichowska M, Boucher H, Kiernan M, DeNofrio D, Inker LA.

Am J Kidney Dis. 2015 Jun;65(6):949-55. doi: 10.1053/j.ajkd.2014.12.020. Epub 2015 Mar 12.

PMID:
25773482
11.

Preoperative three-dimensional echocardiography to assess risk of right ventricular failure after left ventricular assist device surgery.

Kiernan MS, French AL, DeNofrio D, Parmar YJ, Pham DT, Kapur NK, Pandian NG, Patel AR.

J Card Fail. 2015 Mar;21(3):189-97. doi: 10.1016/j.cardfail.2014.12.009. Epub 2014 Dec 20.

PMID:
25535957
12.

Advanced heart failure with preserved systolic function in nonobstructive hypertrophic cardiomyopathy: under-recognized subset of candidates for heart transplant.

Rowin EJ, Maron BJ, Kiernan MS, Casey SA, Feldman DS, Hryniewicz KM, Chan RH, Harris KM, Udelson JE, DeNofrio D, Roberts WC, Maron MS.

Circ Heart Fail. 2014 Nov;7(6):967-75. doi: 10.1161/CIRCHEARTFAILURE.114.001435. Epub 2014 Sep 19.

13.

Self-expanding transcatheter aortic valve replacement using alternative access sites in symptomatic patients with severe aortic stenosis deemed extreme risk of surgery.

Reardon MJ, Adams DH, Coselli JS, Deeb GM, Kleiman NS, Chetcuti S, Yakubov SJ, Heimansohn D, Hermiller J Jr, Hughes GC, Harrison JK, Khabbaz K, Tadros P, Zorn GL 3rd, Merhi W, Heiser J, Petrossian G, Robinson N, Maini B, Mumtaz M, Lee JS, Gleason TG, Resar J, Conte J, Watson D, Chenoweth S, Popma JJ; CoreValve US Clinical Investigators.

J Thorac Cardiovasc Surg. 2014 Dec;148(6):2869-76.e1-7. doi: 10.1016/j.jtcvs.2014.07.020. Epub 2014 Jul 30.

14.

Drive-line infections and sepsis in patients receiving the HVAD system as a left ventricular assist device.

John R, Aaronson KD, Pae WE, Acker MA, Hathaway DR, Najarian KB, Slaughter MS; HeartWare Bridge to Transplant ADVANCE Trial Investigators.

J Heart Lung Transplant. 2014 Oct;33(10):1066-73. doi: 10.1016/j.healun.2014.05.010. Epub 2014 Jun 4.

PMID:
25087103
15.

Bivalirudin for treatment of LVAD thrombosis: a case series.

Sylvia LM, Ordway L, Pham DT, DeNofrio D, Kiernan M.

ASAIO J. 2014 Nov-Dec;60(6):744-7. doi: 10.1097/MAT.0000000000000122.

PMID:
25072553
16.

Transcatheter aortic-valve replacement with a self-expanding prosthesis.

Adams DH, Popma JJ, Reardon MJ, Yakubov SJ, Coselli JS, Deeb GM, Gleason TG, Buchbinder M, Hermiller J Jr, Kleiman NS, Chetcuti S, Heiser J, Merhi W, Zorn G, Tadros P, Robinson N, Petrossian G, Hughes GC, Harrison JK, Conte J, Maini B, Mumtaz M, Chenoweth S, Oh JK; U.S. CoreValve Clinical Investigators.

N Engl J Med. 2014 May 8;370(19):1790-8. doi: 10.1056/NEJMoa1400590. Epub 2014 Mar 29.

17.

Mechanical circulatory support for right ventricular failure.

Kapur NK, Paruchuri V, Jagannathan A, Steinberg D, Chakrabarti AK, Pinto D, Aghili N, Najjar S, Finley J, Orr NM, Tempelhof M, Mudd JO, Kiernan MS, Pham DT, DeNofrio D.

JACC Heart Fail. 2013 Apr;1(2):127-34. doi: 10.1016/j.jchf.2013.01.007. Epub 2013 Apr 1.

PMID:
24621838
18.

Effect of levosimendan on the short-term clinical course of patients with acutely decompensated heart failure.

Packer M, Colucci W, Fisher L, Massie BM, Teerlink JR, Young J, Padley RJ, Thakkar R, Delgado-Herrera L, Salon J, Garratt C, Huang B, Sarapohja T; REVIVE Heart Failure Study Group.

JACC Heart Fail. 2013 Apr;1(2):103-11. doi: 10.1016/j.jchf.2012.12.004. Epub 2013 Apr 1.

PMID:
24621834
19.

Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trial.

Chen HH, Anstrom KJ, Givertz MM, Stevenson LW, Semigran MJ, Goldsmith SR, Bart BA, Bull DA, Stehlik J, LeWinter MM, Konstam MA, Huggins GS, Rouleau JL, O'Meara E, Tang WH, Starling RC, Butler J, Deswal A, Felker GM, O'Connor CM, Bonita RE, Margulies KB, Cappola TP, Ofili EO, Mann DL, Dávila-Román VG, McNulty SE, Borlaug BA, Velazquez EJ, Lee KL, Shah MR, Hernandez AF, Braunwald E, Redfield MM; NHLBI Heart Failure Clinical Research Network.

JAMA. 2013 Dec 18;310(23):2533-43. doi: 10.1001/jama.2013.282190.

20.

Evaluation of myocardial mechanics with three-dimensional speckle tracking echocardiography in heart transplant recipients: comparison with two-dimensional speckle tracking and relationship with clinical variables.

Urbano-Moral JA, Arias-Godinez JA, Ahmad R, Malik R, Kiernan MS, DeNofrio D, Pandian NG, Patel AR.

Eur Heart J Cardiovasc Imaging. 2013 Dec;14(12):1167-73. doi: 10.1093/ehjci/jet065. Epub 2013 Apr 23.

PMID:
23612501

Supplemental Content

Loading ...
Support Center